Search for: "MAJOR PHARMACEUTICALS" Results 1061 - 1080 of 4,361
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 Mar 2019, 11:45 am by Tom Lamb
We also required the drug manufacturer, Takeda Pharmaceuticals, to conduct a large postmarket clinical trial to evaluate the cardiovascular safety of Uloric.... [read post]
19 Feb 2019, 6:30 am by Rebecca Shafer, J.D.
The majority of workers at some point in a career sustain a minor injury at work. [read post]
19 Feb 2019, 3:15 am by Hui Zhang
For pharmaceutical patents, the court will consider public access to drugs and drug safety. [read post]
14 Feb 2019, 7:50 am by Law Offices of Jeffrey S. Glassman
While such mergers may offer cost-savings and other economies for providers, they result in fewer choices for patients and physicians, higher prices, and reduced quality of care, including an increase in mortality and major health setbacks as competition falls. [read post]
14 Feb 2019, 2:00 am by Tinker Ready
The FCA was built with a major incentive encouraging relators to file claims well before the statute of limitations expires. [read post]
12 Feb 2019, 7:04 am by Patrick A. Malone
A spike in hepatitis C infections is a costly, long-term, and major health consequence of the hype and disastrous reformulation of OxyContin, the powerful painkiller made by Purdue Pharmaceuticals owned by the wealthy Sackler family. [read post]
8 Feb 2019, 12:15 pm by IPWatchdog
This week in Other Barks & Bites: the Federal Circuit affirms a Section 101 invalidation of patent claims in favor of Mayo Collaborative Services; Apple wins an order to limit damages in Qualcomm patent case; Google frets over proposed European Union copyright rules; India proposes jail time for film piracy; patent validity challenges drag down the stock of a major pharmaceutical firm; and a snag in the U.S. [read post]
8 Feb 2019, 12:15 pm by IPWatchdog
This week in Other Barks & Bites: the Federal Circuit affirms a Section 101 invalidation of patent claims in favor of Mayo Collaborative Services; Apple wins an order to limit damages in Qualcomm patent case; Google frets over proposed European Union copyright rules; India proposes jail time for film piracy; patent validity challenges drag down the stock of a major pharmaceutical firm; and a snag in the U.S. [read post]
5 Feb 2019, 12:59 pm by Rebecca Tushnet
Instead, a reasonable consumer, considering the “100% Natural” slogan, “could plausibly believe that the infographic’s ‘no additives or artificial ingredients’ statement means no synthetic pharmaceuticals. [read post]
5 Feb 2019, 7:34 am by Lindsay Offutt
The US Senate Finance Committee on Monday invited seven major pharmaceutical companies to the second in a series of hearings exploring the high prices of prescription drugs. [read post]
4 Feb 2019, 5:01 am by James Edward Maule
The healthcare spending problem can only be resolved by fixing the underlying causes, namely, overpriced pharmaceuticals, fraud, inefficiencies, and oligopolies taking over health care practices. [read post]
3 Feb 2019, 9:46 am by Staff Attorney
  There are many investments that are not appropriate for the majority of investors or for certain investors given their risk tolerance, age, and other factors. [read post]
1 Feb 2019, 1:19 pm by Robert Hill and Joseph W. Metro
Late yesterday, the Office of Inspector General (OIG) of the Department of Health and Human Services (HHS) released a proposed rule to amend the anti-kickback safe harbors[1] in response to perceived risks that rebates paid by pharmaceutical manufacturers to payors and pharmacy benefit managers (PBMs) may contribute to pharmaceutical list price inflation and not benefit patients and payors. [read post]
1 Feb 2019, 5:01 am by James Edward Maule
The closest one can get to that ideal system is a tax on real income, This is one major reason, by the way, why I support removal of most exclusions and deductions. [read post]
30 Jan 2019, 2:00 am by Robert Kreisman
” The majority opinion in this case also stated that the trial court committed reversible error in rejecting a special question proffered by the company. [read post]
29 Jan 2019, 7:57 am by Phillips & Associates
When the flight attendant began her employment with a major New Jersey-based pharmaceutical company, she was required to complete something called a “training module. [read post]
29 Jan 2019, 6:32 am by Andrew Hamm
In an op-ed for Macomb (Michigan) Daily, Alan Loncar suggests that recent actions by the court’s conservative majority indicate that a “proper realignment of our constitutional moorings may be coming. [read post]
24 Jan 2019, 4:14 am by Edith Roberts
Teva Pharmaceuticals, in which the court held that an invention is “on sale,” and therefore cannot be patented, if the inventor made a “secret sale” of the invention before seeking a patent. [read post]
22 Jan 2019, 2:30 am by Tinker Ready
Witnesses had seen a burgundy-colored sedan similar to McKreith’s Mercedes-Benz outside a majority of the robberies. [read post]